This dataset presents the footprint of participation statistics in the National Bowel Cancer Screening Program (NBCSP) for people aged 50 to 74. The NBCSP began in 2006. It aims to reduce morbidity and mortality from bowel cancer by actively recruiting and screening the eligible target population for early detection or prevention of the disease. The data spans the years of 2014-2017 and is aggregated to 2015 Department of Health Primary Health Network (PHN) areas, based on the 2011 Australian Statistical Geography Standard (ASGS). Cancer is one of the leading causes of illness and death in Australia. Cancer screening programs aim to reduce the impact of selected cancers by facilitating early detection, intervention and treatment. Australia has three cancer screening programs: BreastScreen Australia National Cervical Screening Program (NCSP) National Bowel Cancer Screening Program (NBCSP) The National cancer screening programs participation data presents the latest cancer screening participation rates and trends for Australia's 3 national cancer screening programs. The data has been sourced from the Australian Institute of Health and Welfare (AIHW) analysis of National Bowel Cancer Screening Program register data, state and territory BreastScreen Australia register data and state and territory cervical screening register data. For further information about this dataset, visit the data source:Australian Institute of Health and Welfare - National Cancer Screening Programs Participation Data Tables. Please note: AURIN has spatially enabled the original data using the Department of Health - PHN Areas. Participation rates represent the percentage of people invited to screen through the NBCSP during the relevant 2-year period, who returned a completed screening test within that period or by 30 June of the following year. The number of individuals invited to screen excludes those who deferred or opted out without completing their screening test. PHN areas were assigned to NBCSP invitees using an SA1 to PHN correspondence. Those invitees without reliable SA1 details were mapped with a postcode to PHN correspondence instead, which may lead to some minor inaccuracies in results. Some invitee SA1 codes and postcodes cannot be attributed to a PHN. These invitees were included in an 'Unknown' group where applicable. Some postcodes cross PHN boundaries, leading to slight inaccuracies. The time period of some PHN data presented is prior to the initiation of PHNs, which were in established in June 2015. Biennial screening for those aged 50-74 is not fully rolled out. During the time period reported, the specific ages invited within the 50-74 age range included 50, 54, 55, 58, 60, 64, 65, 68, 70, 72 and 74. These results calculate participation rates using the new NBCSP performance indicator specifications. This indicator now measures a 2-year invitation period and also excludes those who opted off or suspended participation. Therefore, these results cannot be compared to rates reported prior to 2014. NBCSP participation rates per area are not related to bowel cancer incidence rates.

This dataset presents the uptake rate of bowel cancer screening among eligible individuals aged 60 to 75 in England. It measures the percentage of those who, after receiving an invitation to participate in the Bowel Cancer Screening Programme (BCSP), responded and were adequately screened within six months. The data is sourced from NHS England and provides insight into screening engagement at the general practice level.

Rationale

Bowel cancer screening is a critical public health intervention aimed at early detection and treatment of colorectal cancer. Increasing the percentage of eligible individuals who complete screening can lead to earlier diagnoses, improved outcomes, and reduced mortality. This indicator supports efforts to monitor and enhance participation in cancer screening programmes, aligning with broader goals to improve cancer detection rates across the population.

Numerator

The numerator is defined as the number of persons registered to a general practice, aged 60 to 75, who were invited for bowel cancer screening in the previous 12 months and were adequately screened following an initial response within six months of the invitation.

Denominator

The denominator includes the total number of persons aged 60 to 74 who were invited for bowel cancer screening in the previous 12 months.

Caveats

This indicator may be based on a small number of patients for some practices, which can affect reliability. Additionally, data may be less reliable during periods of GP practice mergers or boundary changes. For data up to 2021/22, only practices with a list size of at least 1,000 were included.

External References

More information can be found on the Fingertips Public Health Profiles website.

Localities ExplainedThis dataset contains data based on either the resident locality or registered locality of the patient, a distinction is made between resident locality and registered locality populations:Resident Locality refers to individuals who live within the defined geographic boundaries of the locality. These boundaries are aligned with official administrative areas such as wards and Lower Layer Super Output Areas (LSOAs).Registered Locality refers to individuals who are registered with GP practices that are assigned to a locality based on the Primary Care Network (PCN) they belong to. These assignments are approximate—PCNs are mapped to a locality based on the location of most of their GP surgeries. As a result, locality-registered patients may live outside the locality, sometimes even in different towns or cities.This distinction is important because some health indicators are only available at GP practice level, without information on where patients actually reside. In such cases, data is attributed to the locality based on GP registration, not residential address.

Click here to explore more from the Birmingham and Solihull Integrated Care Partnerships Outcome Framework.

The proportion of eligible men and women aged 60 to 74 invited for screening who had an adequate faecal occult blood test (FOBt) screening result in the previous 30 months.

RationaleBowel cancer screening supports early detection of cancer and polyps which are not cancers but may develop into cancers over time. About one in 20 people in the UK will develop bowel cancer during their lifetime. This indicator provides an opportunity to incentivise screening promotion and other local initiatives to increase coverage of bowel cancer screening. Improvements in coverage would mean more bowel cancers are detected at earlier, more treatable stages, and more polyps are detected and removed, reducing the risk of bowel cancer developing.

Definition of numeratorAdequately screened (numerator) is the number of eligible men and women who have had an adequate gFOBT screening result recorded in the past 30 months.

Definition of denominatorEligible population (denominator) is the number of men and women aged 60 to 74 years resident in the area (determined by postcode of residence) who are eligible for bowel cancer screening at a given point in time, excluding those whose recall has been ceased for clinical reasons (e.g. no functioning colon) or if they opt out of the programme.

CaveatsData for ICBs are estimated from local authority data. In most cases ICBs are coterminous with local authorities, so the ICB figures are precise. In cases where local authorities cross ICB boundaries, the local authority data are proportionally split between ICBs, based on population located in each ICB.The affected ICBs are:Bath and North East Somerset, Swindon and Wiltshire;Bedfordshire, Luton and Milton Keynes;Buckinghamshire, Oxfordshire and Berkshire West;Cambridgeshire and Peterborough;Frimley;Hampshire and Isle of Wight;Hertfordshire and West Essex;Humber and North Yorkshire;Lancashire and South Cumbria;Norfolk and Waveney;North East and North Cumbria;Suffolk and North East Essex;Surrey Heartlands;Sussex;West Yorkshire.Please be aware that the April 2019 to March 2020, April 2020 to March 2021 and April 2021 to March 2022 data covers the time period affected by the COVID19 pandemic and therefore data for this period should be interpreted with caution.This indicator gives screening coverage by local authority of residence. This is not the same as the indicator based on population registered with primary care organisations which include patients wherever they live. This is likely to result in different England totals depending on selected (registered or resident) population footprint.The indicator excludes women outside the target age range for the screening programme who may self-refer for screening.The data for bowel screening indicators has been refreshed for all years, back to the 2013 to 2014 financial year. This is due to a methodology change, to ensure the data periods run up to the end of March in the given financial year.

This statistic displays the percentage of U.S. adults aged between 50 to 75 years who were up to date with colorectal cancer screening as of 2018, by ethnicity. About ** percent of white survey respondents indicated that they were up to date with colorectal cancer screening. Standard preventative screening includes a fecal occult blood tests within * year, sigmoidoscopy within 5 years and fecal occult blood test within 3 years, or colonoscopy within 10 years.

This statistic displays the percentage of U.S. adults aged between 50 to 75 years who were up to date with colorectal cancer screening as of 2018, by age. Around 79 percent of survey respondents aged 65 to 75 years indicated that they were up to date with colorectal cancer screening. Standard preventative screening includes a fecal occult blood tests within 1 year, sigmoidoscopy within 5 years and fecal occult blood test within 3 years, or colonoscopy within 10 years.

National database to support the Bowel Cance Screening Programme (BCSP)

The interactive Cancer Services profile tool has been updated to include the latest financial year of data that are available, collated by the National Disease Registration Service (NDRS). For most indicators, for example on screening, diagnostics and urgent suspected cancer referrals, the latest data is now available for the financial year 2022 to 2023. For the cancer incidence indicator, the tool has been updated to include the 2021 to 2022 data.

Some racial and ethnic categories are suppressed for privacy and to avoid misleading estimates when the relative standard error exceeds 30% or the unweighted sample size is less than 50 respondents. Margins of error are estimated at the 90% confidence level.

Data Source: Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey (BRFSS) Data

Why This Matters

Colorectal cancer is the third leading cause of cancer death in the U.S. for men and women. Although colorectal cancer is most common among people aged 65 to 74, there has been an increase in incidences among people aged 40 to 49.

Nationally, Black people are disproportionately likely to both have colorectal cancer and die from it. Hispanic residents, and especially those with limited English proficiency, report having the lowest rate of colorectal cancer screenings.

Racial disparities in education, poverty, health insurance coverage, and English language proficiency are all factors that contribute to racial gaps in receiving colorectal cancer screenings. Increased colorectal cancer screening utilization has been shown to nearly erase the racial disparities in the death rate of colorectal cancer.

The District Response

The Colorectal Cancer Control Program (DC3C) aims to reduce colon cancer incidence and mortality by increasing colorectal cancer screening rates among District residents.

DC Health’s Cancer and Chronic Disease Prevention Bureau works with healthcare providers to improve the use of preventative health services and provide colorectal cancer screening services.

DC Health maintains the District of Columbia Cancer Registry (DCCR) to track cancer incidences, examine environmental substances that cause cancer, and identify differences in cancer incidences by age, gender, race, and geographical location.

Some invitee SA1 codes and postcodes cannot be attributed to an SA2. These invitees were included in an 'Unknown' group where applicable. Some postcodes cross SA2 boundaries, leading to slight inaccuracies. Biennial screening for those aged 50-74 is not fully rolled out. During the time period reported, the specific ages invited within the 50-74 age range included 50, 54, 55, 58, 60, 64, 65, 68, 70, 72 and 74. These results calculate participation rates using the new NBCSP performance indicator specifications. This indicator now measures a 2-year invitation period and also excludes those who opted off or suspended participation. Therefore, these results cannot be compared to rates reported prior to 2014. NBCSP participation rates per area are not related to bowel cancer incidence rates. SA2 areas with a numerator less than 20 or a denominator less than 100 have been suppressed. SA2 data for the Blue Mountains - South, Christmas Island, Cocos (Keeling) Islands, Illawarra Catchment Reserve, Jervis Bay and Lord Howe Island were suppressed due to reliability concerns from low numbers in these regions. The 2015-2016 period covers 1 January 2015 to 31 December 2016, and the 2016-2017 period covers 1 January 2016 to 31 December 2017. Participation by SA2 is not available for the period 2014-2015.

This study aimed to investigate associations of up-to-date colorectal and cervical cancer screenings at community health centers (CHCs) with ethnicity and language variables at patient-, clinic-, and area-levels, while exploring whether patient-level associations differed based on clinic-level patient language and ethnicity distributions. This was a cross-sectional study using data from multiple sources, including electronic health records, clinic patient panel data, and area-level demographic data. The study sample included English-preferring Hispanic, Spanish-preferring Hispanic, English-preferring non-Hispanic, and non-English-preferring non-Hispanic patients eligible for either colorectal cancer (N = 98,985) or cervical cancer (N = 129,611) screenings in 2019 from 130 CHCs in the OCHIN network in CA, OR, and WA.

As of 2020, less than half of women between the ages 50 and ** had had a colon cancer screening within the last 2 years. This could be in the form of a colonoscopy or a blood stool test. This statistic presents the percentage of U.S. women aged 50 to 64 who had a colon cancer screening within the past 2 years as of 2017 and 2020.

National Bowel Cancer Screening Program for Bowel Cancer in Australia The data is presented by the ACT Government for the purpose of disseminating information for the benefit of the public. The ACT …Show full descriptionNational Bowel Cancer Screening Program for Bowel Cancer in Australia The data is presented by the ACT Government for the purpose of disseminating information for the benefit of the public. The ACT Government has taken great care to ensure the information in this report is as correct and accurate as possible. Whilst the information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information. Differences in statistical methods and calculations, data updates and guidelines may result in the information contained in this report varying from previously published information.

Forecast: Colorectal Cancer Screening (Programme Data) in France 2024 - 2028 Discover more data with ReportLinker!

Forecast: Colorectal Cancer Screening (Programme Data) in Germany 2024 - 2028 Discover more data with ReportLinker!

This statistic depicts the percentage of U.S. patients that had ever received a colorectal cancer screening as of 2016, by location and select demographics. Among those that were considered in poverty and seeking treatment at a health center, 57 percent had ever received a colorectal cancer screening.

While promotional visual imagery can significantly increase CRC screening, the specific impact of messages and imagery among ethnic minorities and individuals from socioeconomically deprived communities needs further exploration. This study informed the development of optimized bowel cancer screening promotion images tailored at the wider audience, South Asian community in the UK, in which screening uptake is only 33% and in India where both awareness and organized screening programs from colorectal cancer is scarce. The research aims to bridge the gap between existing visual health communication methods and their effectiveness among diverse populations, ultimately working to reduce screening disparities and improve early detection rates.

This dataset presents the footprint of participation statistics in the National Cervical Screening Program (NCSP) for women aged 20 to 69, by age group. The NCSP began in 1991. It aims to reduce cervical cancer cases, illness and deaths in Australia. The data spans the years of 2014-2016 and is aggregated to Statistical Area Level 3 (SA3) from the 2011 Australian Statistical Geography Standard (ASGS). Cancer is one of the leading causes of illness and death in Australia. Cancer screening programs aim to reduce the impact of selected cancers by facilitating early detection, intervention and treatment. Australia has three cancer screening programs: BreastScreen Australia National Cervical Screening Program (NCSP) National Bowel Cancer Screening Program (NBCSP) The National cancer screening programs participation data presents the latest cancer screening participation rates and trends for Australia's 3 national cancer screening programs. The data has been sourced from the Australian Institute of Health and Welfare (AIHW) analysis of National Bowel Cancer Screening Program register data, state and territory BreastScreen Australia register data and state and territory cervical screening register data. For further information about this dataset, visit the data source:Australian Institute of Health and Welfare - National Cancer Screening Programs Participation Data Tables. Please note: AURIN has spatially enabled the original data.

Forecast: Colorectal Cancer Screening (Survey Data) in Italy 2024 - 2028 Discover more data with ReportLinker!

Cancer screening programs in Australia - BreastScreen Australia - National Cervical Screening Program - National Bowel Cancer Screening Program

The data is presented by the ACT Government for the purpose of disseminating information for the benefit of the public. The ACT Government has taken great care to ensure the information in this report is as correct and accurate as possible. Whilst the information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information. Differences in statistical methods and calculations, data updates and guidelines may result in the information contained in this report varying from previously published information.

Around **** million colon cancer screenings were conducted at municipalities in Japan in the fiscal year 2023. Municipalities in Japan provide stomach cancer screenings for people aged between 50 and 69 years old, lung cancer, colon cancer, and breast cancer screenings for people aged between 40 and 69 years old, and cervical cancer screenings for people aged from 20 to 69 years old.